HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Brans, R. Articles by Blömeke, B. Search for Related Content PubMed PubMed Citation Articles by Brans, R. Articles by Blömeke, B. Related Collections Molecular Diagnostics and Genetics Drug Monitoring and Toxicology Automation and Analytical Techniques

N-Acetyltransferase 2 Genotyping: An Accurate and Feasible Approach for Simultaneous Detection of the Most Common NAT2 Alleles

¹ Department of Dermatology and Allergology, University Hospital of the RWTH, Aachen, Aachen, Germany;² Department of Ecotoxicology/Toxicology, University Trier, Trier, Germany

^aaddress correspondence to this author at: Department of Ecotoxicology/Toxicology, University Trier, Science Park, Bldg. 24, Sickingenstrasse 96, D-54290 Trier, Germany; fax 49-651-201-3780, e-mail BLOEMEKE@UNI-TRIER.DE

The first 20% of the full text of this article appears below.

N-Acetyltransferase 2 (NAT2; EC 2.3.1.5) is involved in the detoxification of numerous xenobiotics. The human NAT2 gene is highly polymorphic and represents one of the best studied examples of the large interindividual variability of genetic control of drug or xenobiotic metabolism. In addition to the antituberculosis agent isoniazid (1), the first NAT2 substrate discovered, numerous other chemicals possessing a primary aromatic amine or hydrazine group, such as sulfamethazine, procainamide, hydralazine (2), dapsone, nitrazepam, and caffeine, are metabolized by this enzyme. Arylamine chemicals such as benzidine, ß-naphthylamine, and 2-aminofluorene can also be acetylated by NAT2. As early as 1970, Reidenberg et al.(3) reported clinical problems associated with polymorphic acetylation of procainamide. The determination of NAT2 genotype or NAT2 phenotype has been proposed as a way to predict adverse reactions in patients with tuberculosis and before the concomitant administration of procainamide and phenytoin (4).

The proportions of rapid and slow phenotypes vary in different ethnic groups. In Caucasians, 40–70% of individuals have the slow acetylator phenotype, whereas Asian populations have only 10–30% slow acetylators (5). Several single-nucleotide polymorphisms have been identified in the human NAT2 coding region, which are responsible for the observed phenotypes [see Ref. (6); accession no. X14672]. The presence of the NAT2*4 (wild-type) allele defines the NAT2 genotype as rapid, and combinations of the frequently occurring mutant alleles NAT2*5B, *5C, *6A, *7B, and *14 cluster as slow. Allele frequencies in Caucasians are 23% for NAT2*4 (wild type), 1.3% for *5A, 35% for *5B, 5.0% for *5C, 30.5% for *6A, 4.5% . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				J. A. G. Agundez, K. Golka, C. Martinez, S. Selinski, M. Blaszkewicz, and E. Garcia-Martin Unraveling Ambiguous NAT2 Genotyping Data Clin. Chem., August 1, 2008; 54(8): 1390 - 1394. [Abstract] [Full Text] [PDF]